Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Pathology|May 27, 2015
miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathwaysZsuzsanna Lichner, Qiang Ding, Sara Samaan, et al.
The Journal of Urology|September 23, 2003
A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrationsMichael Lein, Maciej Kwiatkowski, Axel Semjonow, et al.
The Journal of Urology|December 13, 2002
Quantitative analysis of kallikrein 15 gene expression in prostate tissueCarsten Stephan, George M Yousef, Andreas Scorilas, et al.
World Journal of Urology|August 22, 2015
The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsyHannes Cash, Andreas Maxeiner, Carsten Stephan, et al.
Pharmaceutical Research|December 25, 2010
New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancerJuan Rodrigues, Claudia Abramjuk, Luis Vásquez, et al.
Oncology|January 6, 2009
Germ cell tumors of the gonads: a selective review emphasizing problems in drug resistance and current therapy optionsMark Schrader, Carsten Kempkensteffen, Frank Christoph, et al.
European Urology Focus|July 21, 2017
Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health IndexMonique J Roobol, Moniek M Vedder, Daan Nieboer, et al.
The Journal of Pathology|November 9, 2004
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survivalGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 7, 2018
Contrast-Enhanced Ultrasound (CEUS) and Quantitative Perfusion Analysis in Patients with Suspicion for Prostate CancerAndreas Maxeiner, Thomas Fischer, Julia Schwabe, et al.
Urologia Internationalis|December 5, 2019
Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate BiopsiesAndreas Maxeiner, Alexander M Nest, Carsten Stephan, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Pathology|May 27, 2015
miRNAs dysregulated in association with Gleason grade regulate extracellular matrix, cytoskeleton and androgen receptor pathwaysZsuzsanna Lichner, Qiang Ding, Sara Samaan, et al.
The Journal of Urology|September 23, 2003
A multicenter clinical trial on the use of complexed prostate specific antigen in low prostate specific antigen concentrationsMichael Lein, Maciej Kwiatkowski, Axel Semjonow, et al.
The Journal of Urology|December 13, 2002
Quantitative analysis of kallikrein 15 gene expression in prostate tissueCarsten Stephan, George M Yousef, Andreas Scorilas, et al.
World Journal of Urology|August 22, 2015
The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsyHannes Cash, Andreas Maxeiner, Carsten Stephan, et al.
Pharmaceutical Research|December 25, 2010
New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancerJuan Rodrigues, Claudia Abramjuk, Luis Vásquez, et al.
Oncology|January 6, 2009
Germ cell tumors of the gonads: a selective review emphasizing problems in drug resistance and current therapy optionsMark Schrader, Carsten Kempkensteffen, Frank Christoph, et al.
European Urology Focus|July 21, 2017
Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health IndexMonique J Roobol, Moniek M Vedder, Daan Nieboer, et al.
The Journal of Pathology|November 9, 2004
Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survivalGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|June 7, 2018
Contrast-Enhanced Ultrasound (CEUS) and Quantitative Perfusion Analysis in Patients with Suspicion for Prostate CancerAndreas Maxeiner, Thomas Fischer, Julia Schwabe, et al.
Urologia Internationalis|December 5, 2019
Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate BiopsiesAndreas Maxeiner, Alexander M Nest, Carsten Stephan, et al.
Pageof 23